NEW DELHI: Indian Pharmaceutical company Cipla has offered to manufacture an antiviral drug for bird flu called Zanamivir (Relenza) that is currently being manufactured by Glaxo Smithkline.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback